Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (COPDGene)
This study is currently recruiting participants.
Verified by National Heart, Lung, and Blood Institute (NHLBI), September 2008
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00608764
  Purpose

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.


Condition
Pulmonary Disease, Chronic Obstructive
Emphysema
Bronchitis, Chronic

MedlinePlus related topics: Bronchitis COPD (Chronic Obstructive Pulmonary Disease) CT Scans Emphysema
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Cross-Sectional
Official Title: Genetic Epidemiology of Chronic Obstructive Pulmonary Disease

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • Forced expiratory volume in 1 second (FEV1) [ Time Frame: Measured at baseline ] [ Designated as safety issue: No ]
  • Emphysema, as shown on chest CT scan [ Time Frame: Measured at baseline ] [ Designated as safety issue: No ]
  • Airway wall thickness on chest CT scan [ Time Frame: Measured at baseline ] [ Designated as safety issue: No ]
  • COPD status (COPD participants versus control group participants) [ Time Frame: Measured at baseline ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Genomic DNA, serum, and plasma will be collected and stored.


Estimated Enrollment: 10500
Study Start Date: November 2007
Estimated Study Completion Date: November 2012
Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
NHW COPD Participants
Non-Hispanic white participants with COPD
NHW Control Group
Non-Hispanic white participants with normal spirometry (do not have COPD)
AA COPD Participants
African-American participants with COPD
AA Control Group
African-American participants with normal spirometry (do not have COPD)

Detailed Description:

COPD is a disease in which the lung airways are damaged and partly obstructed, making it difficult to breathe. Millions of people in the United States have COPD, and it is the fourth leading cause of death in the United States. Symptoms include coughing, excess mucus production, shortness of breath, wheezing, and chest tightness. Emphysema and long-term bronchitis are the two most common manifestations of the disease. The most common risk factor for developing COPD is cigarette smoking; however, only 15% to 20% of smokers develop COPD in their lifetimes. It is not known why some smokers develop COPD and some do not, but certain genetic factors, combined with exposure to cigarette smoke, may increase the likelihood of developing COPD. This study will analyze DNA from current and former cigarette smokers to identify genetic factors and markers that may indicate a predisposition to developing COPD.

This study will enroll African-American and white cigarette smokers and former cigarette smokers both with and without COPD. Participants will attend one study visit during which they will complete questionnaires about lung symptoms, breathing difficulties, medical and family history, and quality of life. They will also undergo blood collection, a physical exam, lung function testing, and a walking test to measure endurance. Participants with COPD will undergo a high resolution computed tomography (CT) chest scan and a medical record review. Study researchers will contact participants twice a year for 5 years to collect follow-up medical information.

  Eligibility

Ages Eligible for Study:   45 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Particpants with COPD will include outpatient clinic patients, patients in registries, previous study participants, and COPD Foundation volunteers.

Participants without COPD will include spouses and friends of study participants with COPD and patients at primary care practices.

Criteria

Inclusion Criteria:

  • At least 10 pack-years of cigarette smoking
  • Spirometry that meets one of four Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages or normal (FEV1 greater than 80% of predicted level and forced expiratory volume in 1 second/forced vital capacity [FEV1/FVC] greater than 0.7)
  • Self-designation of non-Hispanic white or African-American

Exclusion Criteria:

  • Other lung diseases (except for asthma in participants with COPD)
  • Pregnant
  • Cancer (other than skin cancer) in the 5 years prior to study entry
  • Received antibiotics for a COPD exacerbation in the 1 month prior to study entry
  • First- or second-degree relative of a previously enrolled study participant
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00608764

Contacts
Contact: Edwin K. Silverman, MD, PhD 617-525-0856 ed.silverman@channing.harvard.edu
Contact: James D. Crapo, MD 303-398-1720 crapoj@njc.org

Locations
United States, Alabama
University of Alabama at Birmingham Recruiting
Birmingham, Alabama, United States, 35249
Contact: Don Davis     205-996-6601        
Principal Investigator: Mark Dransfield, MD            
United States, California
Los Angeles Biomedical Research Institute Recruiting
Torrance, California, United States, 90502
Contact: Carmen Lopez-Garcia     310-222-8200        
Principal Investigator: Richard Casaburi, MD            
University of California at San Diego Recruiting
San Diego, California, United States, 92103
Contact: Cathy Calvillo     619-471-0818        
Principal Investigator: Joe Ramsdell, MD            
United States, Colorado
National Jewish Health Recruiting
Denver, Colorado, United States, 80206
Contact: Christina Schnell     303-398-1772        
Principal Investigator: Russell Bowler, MD            
United States, Georgia
Morehouse School of Medicine Recruiting
Atlanta, Georgia, United States, 30310
Contact: Jolita Wainwright     404-752-1877        
Contact: Iva Katon-Benitez     404-616-1415        
Principal Investigator: Marilyn Foreman, MD            
United States, Iowa
University of Iowa Recruiting
Iowa City, Iowa, United States, 52242
Contact: Kim Sprenger     319-353-8862        
Principal Investigator: Geoffrey McLennan, MD            
United States, Maryland
Johns Hopkins University Recruiting
Baltimore, Maryland, United States, 21224
Contact: Teresa Concordia     410-550-2449        
Principal Investigator: Robert Wise, MD            
United States, Massachusetts
Brigham and Women's Hospital Recruiting
Boston, Massachusetts, United States, 02115
Contact: Grace Brown     617-732-6272        
Principal Investigator: Dawn DeMeo, MD            
Principal Investigator: Craig Hersh, MD            
Fallon Clinic Recruiting
Worcester, Massachusetts, United States, 01608
Contact: Diane Kirk     508-368-3929        
Principal Investigator: Richard Rosiello, MD            
United States, Michigan
University of Michigan Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Candace Flaherty     734-647-6399        
Principal Investigator: Fernando Martinez, MD            
Ann Arbor VA Medical Center Not yet recruiting
Ann Arbor, Michigan, United States, 48105
Contact: Lisa McCloskey     734-845-3533        
Principal Investigator: Jeffrey Curtis, MD            
United States, Minnesota
HealthPartners Research Foundation Recruiting
Minneapolis, Minnesota, United States, 55440
Contact: Natalie Woodruff     952-967-5493        
Principal Investigator: Charlene McEvoy, MD            
University of Minnesota Not yet recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Cheryl Stibbe     612-625-1435        
Principal Investigator: Chris Wendt, MD            
Minneapolis VA Medical Center Not yet recruiting
Minneapolis, Minnesota, United States, 55417
Contact: Doris Stuber     612-467-5203        
Principal Investigator: Dennis Niewoehner, MD            
United States, New York
Columbia University Medical Center Recruiting
New York, New York, United States, 10032
Contact: Adina Lemeshow     212-305-9821        
Principal Investigator: R. Graham Barr, MD            
United States, North Carolina
Duke University Recruiting
Durham, North Carolina, United States, 27710
Contact: Kim Hamilton     919-684-9428        
Contact: Stephanie Keeting     919-613-6306        
Principal Investigator: Neil MacIntyre, MD            
United States, Pennsylvania
Temple University Recruiting
Philadelphia, Pennsylvania, United States, 19140
Contact: Gretel Ortiz     215-707-9844        
Principal Investigator: Gerard Criner, MD            
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Patty Tomko     412-623-5909        
Principal Investigator: Frank Sciurba, MD            
United States, Texas
Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: Mustafa Atik     713-798-2683        
Principal Investigator: Nicola Hanania, MD            
Houston VA Medical Center Recruiting
Houston, Texas, United States, 77030
Contact: Dorothy Williams     713-794-7668        
Principal Investigator: Amir Sharafkhaneh, MD            
University of Texas Health Sciences Center at San Antonio Recruiting
San Antonio, Texas, United States, 78229
Contact: Nita Zaragoza     210-949-3264        
Principal Investigator: Antonio Anzueto, MD            
Sponsors and Collaborators
Investigators
Principal Investigator: James D. Crapo, MD National Jewish Health
Principal Investigator: Edwin K. Silverman, MD, PhD Brigham and Women's Hospital
  More Information

Responsible Party: Brigham and Women's Hospital ( Edwin K. Silverman, MD, PhD )
Study ID Numbers: 1428, 1 R01 HL089856, 1 R01 HL089897
Study First Received: January 28, 2008
Last Updated: January 14, 2009
ClinicalTrials.gov Identifier: NCT00608764  
Health Authority: United States: Federal Government

Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
Chronic Obstructive Pulmonary Disease
COPD
Emphysema
Chronic Bronchitis
Genetics
Association Studies
Computed Tomography

Study placed in the following topic categories:
Pulmonary Emphysema
Emphysema
Bronchitis, Chronic
Lung Diseases, Obstructive
Respiratory Tract Infections
Respiratory Tract Diseases
Lung Diseases
Respiration Disorders
Chronic Disease
Bronchitis
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes
Bronchial Diseases

ClinicalTrials.gov processed this record on January 16, 2009